Dicerna Pharmaceuticals, Inc. — Net Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7bc19e03-0458-4f80-8d90-e48529244e2a/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2020 | $-112.7M | 2020-01-01 – 2020-12-31 | evidence 0001399529-21-000042 |
| FY 2019 | $-120.5M | 2019-01-01 – 2019-12-31 | evidence 0001399529-20-000009 |
| FY 2018 | $-88.9M | 2018-01-01 – 2018-12-31 | evidence 0001399529-19-000005 |
| FY 2017 | $-60.2M | 2017-01-01 – 2017-12-31 | evidence 0001399529-19-000005 |
| FY 2016 | $-59.5M | 2016-01-01 – 2016-12-31 | evidence 0001193125-17-104169 |
| FY 2015 | $-62.8M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-500111 |
| FY 2014 | $-47.9M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-089221 |
| FY 2013 | $-18.5M | 2013-01-01 – 2013-12-31 | evidence 0001193125-15-089221 |
| FY 2012 | $-10.1M | 2012-01-01 – 2012-12-31 | evidence 0001193125-15-089221 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Dicerna Pharmaceuticals, Inc. — all facts · Revenue · Operating Income